Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Reiner

Showing results (331-340 of 381) with videos related to

Pageof 39
Sort By:
Breast (Edinburgh, Scotland)|September 14, 2020
A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE studyJennifer D Brooks, John D Boice, Roy E Shore, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 23, 2025
Refractory Tumorous and Neurodegenerative Histiocytosis Treated With Intra-Arterial ChemotherapyAlexander Ramos, Andrew L A Garton, Jared Knopman, et al.
Breast Cancer Research : BCR|July 21, 2017
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study populationAnne S Reiner, Charles F Lynch, Julia S Sisti, et al.
The Journal of Invasive Cardiology|July 13, 2022
Direct Comparison of Outcomes After Transcatheter Aortic Valve Replacement in Veterans and Non-Veterans Using the Transcatheter Valve Therapy RegistryMichael A Napolitano, Timothy J Holleran, Andrew D Sparks, et al.
Breast Cancer Research and Treatment|February 6, 2010
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerKerryn W Reding, Jonine L Bernstein, Bryan M Langholz, et al.
Neuro-Oncology Practice|May 11, 2026
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairmentNeil Sielski, Anne S Reiner, William E Rosa, et al.
Neuro-Oncology|February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2008
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE studyMarilyn Stovall, Susan A Smith, Bryan M Langholz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2Kathleen E Malone, Colin B Begg, Robert W Haile, et al.
Breast Cancer Research : BCR|November 18, 2011
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudySharon N Teraoka, Jonine L Bernstein, Anne S Reiner, et al.
Pageof 39

Showing results (331-340 of 381) with videos related to

Sort By:
Pageof 39
Breast (Edinburgh, Scotland)|September 14, 2020
A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE studyJennifer D Brooks, John D Boice, Roy E Shore, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 23, 2025
Refractory Tumorous and Neurodegenerative Histiocytosis Treated With Intra-Arterial ChemotherapyAlexander Ramos, Andrew L A Garton, Jared Knopman, et al.
Breast Cancer Research : BCR|July 21, 2017
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study populationAnne S Reiner, Charles F Lynch, Julia S Sisti, et al.
The Journal of Invasive Cardiology|July 13, 2022
Direct Comparison of Outcomes After Transcatheter Aortic Valve Replacement in Veterans and Non-Veterans Using the Transcatheter Valve Therapy RegistryMichael A Napolitano, Timothy J Holleran, Andrew D Sparks, et al.
Breast Cancer Research and Treatment|February 6, 2010
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerKerryn W Reding, Jonine L Bernstein, Bryan M Langholz, et al.
Neuro-Oncology Practice|May 11, 2026
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairmentNeil Sielski, Anne S Reiner, William E Rosa, et al.
Neuro-Oncology|February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2008
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE studyMarilyn Stovall, Susan A Smith, Bryan M Langholz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2Kathleen E Malone, Colin B Begg, Robert W Haile, et al.
Breast Cancer Research : BCR|November 18, 2011
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudySharon N Teraoka, Jonine L Bernstein, Anne S Reiner, et al.
Pageof 39